Neoplasia (New York, N.Y.)Feb 23, 2025

How the m6A remover ALKBH5, treRNA1, and DDX46 control BCR protein levels

Circadian Biology Weekly Brief ↗PubMed ↗DOI ↗

Updated Mar 28, 2026

Abstract

Epitranscriptomic modifications, particularly N6-methyladenosine (m6A), significantly influence RNA stability and gene expression in immune responses.

m6A modifications are critical for germinal center formation and antigen-driven differentiation in B-cell biology.
ALKBH5 plays a key role in removing m6A modifications and is essential for regulating gene expression in various cellular contexts.
Activation signals prompt ALKBH5 and treRNA1 to move to the nucleus, where they form a complex with DDX46.
This complex facilitates the removal of m6A modifications on transcripts related to B-cell receptor signaling, enhancing their stability and translation.
Loss of ALKBH5, DDX46, or treRNA1 results in impaired processing of transcripts and reduced expression of genes associated with B-cell receptor signaling.
The findings reveal a novel regulatory mechanism that underscores the importance of m6A demethylation in B-cell functionality and immune regulation.

Simplified

Epitranscriptomic modifications, particularly N6-methyladenosine (m6A), have emerged as critical regulators of RNA stability, localization, and translation, shaping immune responses and tumor progression. In B-cell biology, m6A modifications influence germinal center formation and antigen-driven differentiation, underscoring their importance in immune regulation. Among m6A regulators, ALKBH5 (RNA demethylase) is pivotal in removing methylation marks and modulating gene expression in diverse cellular contexts. Despite advancements in understanding m6A dynamics, the mechanistic interplay between m6A demethylation and B-cell receptor (BCR) signaling pathways still needs to be explored. This study reveals a novel regulatory axis involving ALKBH5, treRNA1 (Translation Regulatory Long Non-Coding RNA 1), and DDX46 (RNA helicase). Upon activation signals, ALKBH5 and treRNA1 translocate to the nucleus, forming a functional complex with DDX46 to orchestrate the removal of m6A modifications on key transcripts, including those involved in BCR signaling. This demethylation enhances transcript stability and facilitates cytoplasmic export through interaction with the RNA-binding protein HuR, promoting efficient translation. Disruption of this axis, via loss of ALKBH5, DDX46, or treRNA1, led to impaired transcript processing and diminished BCR-related gene expression, highlighting the critical role of m6A demethylation in maintaining RNA dynamics. These findings uncover a previously unrecognized epitranscriptomic mechanism driven by the ALKBH5-treRNA1-DDX46 complex, with significant implications for B-cell functionality, immune regulation, and oncogenic pathways. Targeting this axis offers a promising avenue for developing therapeutic strategies in cancer and immune-related disorders where m6A dysregulation plays a central role.

Full Text

We can’t show the full text here under this license.

View Full Text ↗

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

PubMed

How the m6A remover ALKBH5, treRNA1, and DDX46 control BCR protein levels

Abstract

Full Text

Funding

Competing interests

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the circadian biology brief

Abstract

Full Text

Funding

Competing interests

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the circadian biology brief